The FDA has granted orphan drug designation to the oral agent OPN-6602 for the treatment of patients with relapsed or ...

An odd thing happened when Coinbase reported its quarterly financial results last week. The bulk of its assets and ...

Therapists Online Therapy Psychiatrists Treatment Centers Support Groups US Log In Sign Up and Get Listed Home Nevada NV Oppositional Defiance (ODD) Oppositional Defiance (ODD) Therapists in ...

Ac-SSO110 has now received FDA orphan drug designation and investigational new drug application clearance for the treatment ...

A dad who has battled four brain tumours has explained how he found one after developing a craving for olives. Dan Horrocks, ...

Ariceum Therapeutics (Ariceum), a private biotech company developing radiopharmaceutical products for the diagnosis and treatment of certain hard-to-treat cancers, today announced that the U.S. Food ...

Rare diseases have become an attractive target for pharmaceutical companies both on the ASX and internationally.

Therapists Online Therapy Psychiatrists Treatment Centers Support Groups US Log In Sign Up and Get Listed Home Colorado CO Pitkin County Aspen Oppositional Defiance (ODD) Oppositional Defiance ...

Egetis Therapeutics AB (publ) ("Egetis" or the "Company") (Nasdaq Stockholm: EGTX), today announced that the European Commission (EC) has approved Emcitate® (tiratricol) ...

Just five months after giving birth to our third (and final) child in 2015, my wife experienced something odd: Her smile ...

Surveys routinely show that a majority of Americans agree that schools should teach about the causes, consequences, and ...

The FDA has granted Fast Track Designation to Lundbeck’s investigational drug, amlenetug, a potential new treatment option targeting Multiple System Atrophy (MSA).